Last reviewed · How we verify
NCT06016595
Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients
trial testing Chronic prostatitis/chronic pelvic pain syndrome in Chronic Prostatitis With Chronic Pelvic Pain Syndrome in 112 participants. Completed in 10 May 2023.
31 December 2022
Quick facts
| Lead sponsor | Hisar Intercontinental Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 112 |
| Start date | 1 January 2020 |
| Primary completion | 31 December 2022 |
| Estimated completion | 10 May 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Chronic prostatitis/chronic pelvic pain syndrome
Conditions studied
- Chronic Prostatitis With Chronic Pelvic Pain Syndrome — all drugs for Chronic Prostatitis With Chronic Pelvic Pain Syndrome →
Sponsor
Hisar Intercontinental Hospital
Who can join
Adults 20 to 60, male only, with Chronic Prostatitis With Chronic Pelvic Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Chronic prostatitis/chronic pelvic pain syndrome (CPPS) is a common health problem among men and can cause severe quality of life. The pathophysiology of CPPS is still poorly understood and effective treatments are a challenging issue. This study aims to investigate the possible relationship between the presence of microorganisms in the prostatic fluid and symptom severity by presenting a retrospective analysis based on data from CPPS patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06016595
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Currently open trials in the same condition.
- NCT06299683 — Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment · NA · recruiting
- NCT06345014 — The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome · Phase 4 · recruiting
Other Hisar Intercontinental Hospital trials
Trials by the same sponsor.
- NCT07260201 — Triglyceride-Glucose and TGI-BMI Indices Compared With HOMA-IR · completed
- NCT06584981 — Effect of PECS II, Parasternal and Serratus Plane Blocks on Postoperative Pain in MIDCAB Surgery · NA · completed
- NCT06459713 — Multiplex Respiratory PCR Results in Diabetic Pneumonia Cases · completed
- NCT05175027 — Preoperative Antiseptic in Newborn Circumcision Comparison of Povidone Iodine and Hypochlorous Acid Used · NA · completed
- NCT06257654 — One-year Results After Single-center Water Vapor Thermal Therapy for Symptomatic Benign Prostatic Hyperplasia. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06016595 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hisar Intercontinental Hospital
- Last refreshed: 29 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06016595.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing